Jan. 26, 2023 —Chemists designed a bottlebrush-shaped nanoparticle that can be loaded with multiple drugs, in ratios that can be easily controlled. Using these particles, the researchers calculated and delivered ...
Dec. 22, 2022 —Researchers have demonstrated that people suffering from blood cancer have a good immune response to COVID-19 vaccinations. Vaccination protects patients with B-cell lymphoma and multiple myeloma ...
Dec. 20, 2022 —In our bones, specialized cells called osteoblasts are responsible for building up bone substance. A team of researchers has now identified an enzyme ...
Sep. 6, 2022 —New CT technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease associated with multiple myeloma at lower radiation doses than conventional ...
Sep. 1, 2022 —Researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line ...
June 5, 2022 —Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. ...
May 19, 2022 —A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this ...
Mar. 1, 2022 —Multiple myeloma, the most common type of bone marrow cancer in Germany, almost always returns, even after initial treatment success. In the majority of cases, the reasons behind this treatment ...
Jan. 12, 2022 —Multiple myeloma is a cancer of the bone marrow, with a life expectancy of less than 5 years post-diagnosis. Proteasome inhibitors, the therapeutic backbone of current treatments, are very effective ...
Oct. 12, 2021 —A researcher has discovered an enzyme that plays a key role in the ability of cancer cells to resist ...